Becker's ASC

Author's posts

The issue dividing ASC owners

ASC growth and expansion can be an uphill battle for independent centers. A controversial trend makes it easier for some and harder for others.

Medical office building housing orthopedic ASC sells for $24.9M

Principal Real Estate Investors has purchased a 59,205-square-foot medical office building that houses a surgery center that opened in early 2021, the New England Real Estate Journal reported Feb. 4.

Top 10 states for malpractice suits

Indiana was the leading state for malpractice lawsuits, according to Medscape’s “Malpractice Report 2021.”

HCA Healthcare hiring 11 ASC administrators 

Nashville, Tenn.-based HCA Healthcare is hiring 11 surgery center administrators nationally. 

Raising colorectal screening rates could be as simple as an automated message

Colorectal cancer screening rates could be improved if health systems include a “primer message” to patients on their patient portals, a study published Feb. 4 in JAMA Network suggests.

8 developments in GI technology

Here are eight key updates on gastroenterology medtech in the last three months:

GI physicians can stay independent while partnering with hospitals, says exec

Tracy Belsan, market president for Jamison, Pa.-based PE GI Solutions, joined “Becker’s ASC Review Podcast” to talk about the importance of independence among gastroenterologists.

Hospitals need partnerships with ASCs, says GI exec

Tracy Belsan, market president for Jamison, Pa.-based PE GI Solutions, joined “Becker’s ASC Review Podcast” to talk about how much interest hospitals continue to have in gastroenterology ASCs and other surgery centers.

What physicians in 29 specialties earn

Plastic surgeons continue to earn the highest average salaries among specialists, with orthopedic surgeons following close behind, according to Physicians Thrive’s 2022 Physician Compensation Report.

Breakthrough vision loss treatment spurred by Iowa clinic trials

Trials at Marshalltown, Iowa-based Wolfe Eye Clinic have led to the approval of a treatment for two vision loss diseases.